Daun02-10 mg

10 mg

SKU: HY-13061-10 mg Category: Tags: ,

Description

Daun02 is a proagent of the topoisomerase inhibitor Daunorubicin. –20°C, 3 years; 4°C, 2 years (Powder)-Applications-Cancer-programmed cell death-Formula-C41H44N2O20-Citation–References-[1]Koya E, et al. Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization. Nat Neurosci. 2009 Aug;12(8):1069-73.|[2]Farquhar D, et al. Suicide gene therapy using E. coli beta-galactosidase.Cancer Chemother Pharmacol. Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70.|[3]Lehmann M, et al. Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test. Environ Mol Mutagen. 2004;43(4):250-7.-CASNumber-290304-24-4-MolecularWeight-884.79-Compound Purity-98.72-SMILES-O[C@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O)OC2=CC=C(C=C2[N+]([O-])=O)COC(N[C@@H]3[C@@H]([C@@H](O[C@H](C3)O[C@H]4C[C@](C(C)=O)(CC5=C(C(C(C6=C7C(OC)=CC=C6)=O)=C(C(O)=C54)C7=O)O)O)C)O)=O)CO-Research_Area-Cancer-Solubility-DMSO : ≥ 100 mg/mL-Target-ADC Cytotoxin;Topoisomerase-Isoform-Daunorubicins/Doxorubicins;Topoisomerase-Pathway-Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage-MCE Product type-ADC Related

Brand

MEDCHEM EXPRESS

©2024. ALFAGEN. All Rights Reserved.